PG

Priyeshbhai Girishbhai Doshi

Active Director Director DIN 10497490
DIN 10497490 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Priyeshbhai Girishbhai Doshi

Data last updated:

Priyeshbhai Girishbhai Doshi is a Director at Weilai International Private Limited (since 2024). The company operates in Pharma.

DIN 10497490
Primary Designation Director
Industry Pharma
First Appointment 07 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Weilai International Private Limited U46497GJ2024PTC148428
Director07 Feb 20242024Active

Directorship timeline

Open interactive timeline →
Weilai International Private Limited
Premium access

Shareholding and investment profile for Priyeshbhai Girishbhai Doshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyeshbhai Girishbhai Doshi

Priyeshbhai Girishbhai Doshi currently holds 1 directorship: Weilai International Private Limited (Director, since 07 Feb 2024).

Priyeshbhai Girishbhai Doshi was first appointed on 07 Feb 2024 as Director at Weilai International Private Limited.

The current boards of Priyeshbhai Girishbhai Doshi's companies include Bharatkumar Shivlal Patel (Weilai International Private Limited), Jay Nileshbhai Thummar (Weilai International Private Limited), Manishkumar Dhirajlal Gadhia (Weilai International Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available